Hangzhou AGS Medtech(688581.SH) granted 391,500 restricted shares at a price of 70 yuan per share.
Hangzhou AGS Medtech(688581.SH) announcement, the restrictive stock grant conditions stipulated in the company's 2023 restricted stock incentive plan have been achieved. The company has determined September 7, 2023 as the initial grant date for the restricted stocks of this equity incentive plan. It will grant 391,500 restricted stocks at a price of 70 yuan per share to 69 eligible incentive recipients.
Related Articles

Trump threatens Iran again to open the Strait of Hormuz

Wall Street on edge: After Trump's ultimatum is rejected, which way will the market go?

The Chinese AI boom ignites the capital market, with Hong Kong stocks reaching a five-year high in financing scale in Q1.
Trump threatens Iran again to open the Strait of Hormuz

Wall Street on edge: After Trump's ultimatum is rejected, which way will the market go?

The Chinese AI boom ignites the capital market, with Hong Kong stocks reaching a five-year high in financing scale in Q1.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


